Dyslipidemia is divided up into primary and secondary types. Cardiovascular disease affects more than onethird of american adults and is the leading cause of mortality in the united states and worldwide. Cardiopatias 35%, condicion oncologica % y dislipidemia 10%. Determine a patients risk for coronary heart disease and treatment goals. Nutrition is an important treatment for dyslipidemia, chd risk factors, and the prevention and treatment of cvd. Russell, pharmd, bcps, cde pon successful completion of this continuing education activity, the pharmacist should be able to. Guidlies for the diagnosis and management of dyslipidemia. Treatment overview of dyslipidemia dyslipidemia is a powerful risk factor for coronary heart disease chd. Treatment of lipid disorders also helps prevent stroke and peripheral arterial disease. Dyslipidemia is a major risk factor for atherosclerosis. Over the past several years the organization justhope. Coronary heart disease chd the etiology of atherosclerosis is multifactorial but the causeeffect relationship between dyslipidemia and.
Ada cuevas manejo dislipidemia en mujeres y adulto mayor dr. Dyslipidemia is elevation of plasma cholesterol, triglycerides tgs, or both, or a low hdl cholesterol level that contributes to the development of atherosclerosis. Longterm, prospective epidemiologic studies have consistently shown that persons with healthier lifestyles and fewer risk factors for coronary heart disease, and particularly those with favorable lipid profiles, have reduced incidence of coronary heart disease. Mark houston md, ms, msc, in integrative medicine fourth edition, 2018.
Diagnosis is by measuring plasma levels of total cholesterol, tgs, and individual lipoproteins. Numerous epidemiological studies and prospective clinical trials, 5481 including the framingham heart study, 54,55 seven countries study, 56,57 pritikin diet studies, 5860 ornish. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease. Dyslipidemia current therapies guidelines usc journal. Dyslipidemia endocrine and metabolic disorders msd. Dyslipidemia is an important risk factor for coronary artery disease and stroke. Case studies in the management of dyslipidemia by shana lettieri, pharmd, and tricia m. Clinical trials conclusively have demonstrated that treatment of lipid disorders can reduce chd morbidity and mortality. Atherosclerosis is a disease process that affects the coronary, cerebral and peripheral arterial circulation.